OVERVIEW


clinical-trial-unit-2.jpg

BNAC is a dedicated research center for quantitative analysis of MRI for clinical research including Phase I, II, III, and IV clinical trials and investigator-led research studies on multiple sclerosis and other neurodegenerative diseases. Our experienced staff provides top-quality service by using state-of-the art and innovative technology. In chronic neurological diseases with a high degree of longitudinal variability in clinical signs and symptoms within and between patients, there are at present no current adequate biological markers of disease progression. Thus, quantitative imaging techniques serve as powerful instruments for non-invasive evaluation. Different quantitative MRI markers are tracked, i.e., assessed upon diagnosis and monitored over time to determine any changes. Since its inception, BNAC research projects have involved international collaboration with a variety of clinicians, scientists and pharmaceutical industries pursuing the use of qualitative and quantitative MRI to study brain disorders. The BNAC has participated in more than $25 million in research grants.

BNAC offers the following services, which can be tailored to each study sponsor’s needs.

  • Personnel Training
  • Trial Design Assistance
  • MRI Protocol and Technologist Manual Development
  • Dummy Run Scan Assistance Program
  • Clinical Trial Call Center
  • Scan Acceptance Assistance Program
  • MR Outcome Measures Calculations
  • MRI Status Reports and Compliance Documentation
  • Secure Electronic Data Transfer
  • Quality Assurance Program
  • Post-Analysis Data Processing
  • Publications and Report Dissemination


BNAC ensures fast contracting, ethical committee approval and start-up processes, and is structured to manage multiple projects with tens of thousands of scans. BNAC brings to every clinical trial a high degree of professionalism and integrity that stipulates unequivocal respect for deadlines and commitments.